HEADER MEMBRANE PROTEIN 29-DEC-20 7DRT TITLE HUMAN WNTLESS IN COMPLEX WITH WNT3A COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEIN WNT-3A; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: PROTEIN WNTLESS HOMOLOG; COMPND 7 CHAIN: B; COMPND 8 SYNONYM: INTEGRAL MEMBRANE PROTEIN GPR177,PROTEIN EVENNESS COMPND 9 INTERRUPTED HOMOLOG,EVI,PUTATIVE NF-KAPPA-B-ACTIVATING PROTEIN 373; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: WNT3A; SOURCE 6 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: HEK293; SOURCE 9 MOL_ID: 2; SOURCE 10 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 11 ORGANISM_COMMON: HUMAN; SOURCE 12 ORGANISM_TAXID: 9606; SOURCE 13 GENE: WLS, C1ORF139, GPR177, UNQ85/PRO18667; SOURCE 14 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 15 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 16 EXPRESSION_SYSTEM_CELL_LINE: HEK293 KEYWDS WNT SIGNALING; WNT SECRETION; WLS; WNT3A; CRYO-EM; PALMITOLEOYLATION; KEYWDS 2 MEMBRANE PROTEIN, MEMBRANE PROTEIN EXPDTA ELECTRON MICROSCOPY AUTHOR Q.ZHONG,Y.ZHAO,F.YE,Z.XIAO,G.HUANG,Y.ZHANG,P.LU,W.XU,Q.ZHOU,D.MA REVDAT 2 08-SEP-21 7DRT 1 JRNL REVDAT 1 14-JUL-21 7DRT 0 JRNL AUTH Q.ZHONG,Y.ZHAO,F.YE,Z.XIAO,G.HUANG,M.XU,Y.ZHANG,X.ZHAN, JRNL AUTH 2 K.SUN,Z.WANG,S.CHENG,S.FENG,X.ZHAO,J.ZHANG,P.LU,W.XU,Q.ZHOU, JRNL AUTH 3 D.MA JRNL TITL CRYO-EM STRUCTURE OF HUMAN WNTLESS IN COMPLEX WITH WNT3A. JRNL REF NAT COMMUN V. 12 4541 2021 JRNL REFN ESSN 2041-1723 JRNL PMID 34315898 JRNL DOI 10.1038/S41467-021-24731-3 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : RELION REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : NULL REMARK 3 REFINEMENT PROTOCOL : NULL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 2.200 REMARK 3 NUMBER OF PARTICLES : 848233 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE REMARK 3 CORRECTION REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 7DRT COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 04-JAN-21. REMARK 100 THE DEPOSITION ID IS D_1300020018. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : HUMAN WNTLESS IN COMPLEX WITH REMARK 245 WNT3A; WNT3A; WNTLESS REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : NULL REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 8.00 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : FEI TITAN KRIOS REMARK 245 DETECTOR TYPE : GATAN K3 BIOQUANTUM (6K X REMARK 245 4K) REMARK 245 MINIMUM DEFOCUS (NM) : NULL REMARK 245 MAXIMUM DEFOCUS (NM) : NULL REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : NULL REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 5000.00 REMARK 245 ILLUMINATION MODE : FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, H REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ALA A 2 REMARK 465 PRO A 3 REMARK 465 LEU A 4 REMARK 465 GLY A 5 REMARK 465 TYR A 6 REMARK 465 PHE A 7 REMARK 465 LEU A 8 REMARK 465 LEU A 9 REMARK 465 LEU A 10 REMARK 465 CYS A 11 REMARK 465 SER A 12 REMARK 465 LEU A 13 REMARK 465 LYS A 14 REMARK 465 GLN A 15 REMARK 465 ALA A 16 REMARK 465 LEU A 17 REMARK 465 GLY A 18 REMARK 465 MET B 1 REMARK 465 ALA B 2 REMARK 465 TYR B 499 REMARK 465 GLY B 500 REMARK 465 GLU B 501 REMARK 465 ASP B 502 REMARK 465 GLN B 503 REMARK 465 SER B 504 REMARK 465 ASN B 505 REMARK 465 GLY B 506 REMARK 465 ASP B 507 REMARK 465 LEU B 508 REMARK 465 GLY B 509 REMARK 465 VAL B 510 REMARK 465 HIS B 511 REMARK 465 SER B 512 REMARK 465 GLY B 513 REMARK 465 GLU B 514 REMARK 465 GLU B 515 REMARK 465 LEU B 516 REMARK 465 GLN B 517 REMARK 465 LEU B 518 REMARK 465 THR B 519 REMARK 465 THR B 520 REMARK 465 THR B 521 REMARK 465 ILE B 522 REMARK 465 THR B 523 REMARK 465 HIS B 524 REMARK 465 VAL B 525 REMARK 465 ASP B 526 REMARK 465 GLY B 527 REMARK 465 PRO B 528 REMARK 465 THR B 529 REMARK 465 GLU B 530 REMARK 465 ILE B 531 REMARK 465 TYR B 532 REMARK 465 LYS B 533 REMARK 465 LEU B 534 REMARK 465 THR B 535 REMARK 465 ARG B 536 REMARK 465 LYS B 537 REMARK 465 GLU B 538 REMARK 465 ALA B 539 REMARK 465 GLN B 540 REMARK 465 GLU B 541 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OG SER A 209 C1 PAM A 501 1.55 REMARK 500 SG CYS A 128 SG CYS A 136 1.79 REMARK 500 ND2 ASN A 87 C1 NAG H 1 2.06 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR A 20 -43.44 -144.33 REMARK 500 PRO A 30 -19.05 -47.72 REMARK 500 LEU A 35 53.17 -113.45 REMARK 500 ILE A 45 99.78 -53.60 REMARK 500 TYR A 59 75.01 -117.14 REMARK 500 ARG A 85 -57.33 71.72 REMARK 500 CYS A 88 31.74 74.63 REMARK 500 ALA A 96 78.39 -160.85 REMARK 500 GLN A 143 66.31 178.01 REMARK 500 SER A 145 121.95 -35.49 REMARK 500 TRP A 152 -52.37 -127.55 REMARK 500 PRO A 177 87.61 -69.91 REMARK 500 PRO A 266 -161.12 -106.38 REMARK 500 ARG A 269 -24.12 -150.04 REMARK 500 SER A 300 -80.63 -99.08 REMARK 500 CYS A 312 14.11 54.50 REMARK 500 ALA A 318 -23.59 -143.82 REMARK 500 HIS A 332 164.51 -49.84 REMARK 500 CYS A 334 -70.04 -122.52 REMARK 500 TYR A 336 60.47 34.14 REMARK 500 HIS B 57 -72.77 -113.49 REMARK 500 ASN B 88 -5.10 82.61 REMARK 500 PHE B 145 55.88 -97.33 REMARK 500 PRO B 170 49.96 -72.35 REMARK 500 PHE B 184 -64.50 -132.89 REMARK 500 GLN B 326 -14.71 77.92 REMARK 500 HIS B 327 -126.67 -122.39 REMARK 500 PHE B 365 50.50 -106.22 REMARK 500 MET B 417 -165.46 -116.60 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 NAG H 1 REMARK 610 PAM A 501 REMARK 610 PCW A 502 REMARK 610 LPE B 602 REMARK 610 PCW B 603 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-30827 RELATED DB: EMDB REMARK 900 HUMAN WNTLESS IN COMPLEX WITH WNT3A DBREF 7DRT A 1 352 UNP P56704 WNT3A_HUMAN 1 352 DBREF 7DRT B 1 541 UNP Q5T9L3 WLS_HUMAN 1 541 SEQRES 1 A 352 MET ALA PRO LEU GLY TYR PHE LEU LEU LEU CYS SER LEU SEQRES 2 A 352 LYS GLN ALA LEU GLY SER TYR PRO ILE TRP TRP SER LEU SEQRES 3 A 352 ALA VAL GLY PRO GLN TYR SER SER LEU GLY SER GLN PRO SEQRES 4 A 352 ILE LEU CYS ALA SER ILE PRO GLY LEU VAL PRO LYS GLN SEQRES 5 A 352 LEU ARG PHE CYS ARG ASN TYR VAL GLU ILE MET PRO SER SEQRES 6 A 352 VAL ALA GLU GLY ILE LYS ILE GLY ILE GLN GLU CYS GLN SEQRES 7 A 352 HIS GLN PHE ARG GLY ARG ARG TRP ASN CYS THR THR VAL SEQRES 8 A 352 HIS ASP SER LEU ALA ILE PHE GLY PRO VAL LEU ASP LYS SEQRES 9 A 352 ALA THR ARG GLU SER ALA PHE VAL HIS ALA ILE ALA SER SEQRES 10 A 352 ALA GLY VAL ALA PHE ALA VAL THR ARG SER CYS ALA GLU SEQRES 11 A 352 GLY THR ALA ALA ILE CYS GLY CYS SER SER ARG HIS GLN SEQRES 12 A 352 GLY SER PRO GLY LYS GLY TRP LYS TRP GLY GLY CYS SER SEQRES 13 A 352 GLU ASP ILE GLU PHE GLY GLY MET VAL SER ARG GLU PHE SEQRES 14 A 352 ALA ASP ALA ARG GLU ASN ARG PRO ASP ALA ARG SER ALA SEQRES 15 A 352 MET ASN ARG HIS ASN ASN GLU ALA GLY ARG GLN ALA ILE SEQRES 16 A 352 ALA SER HIS MET HIS LEU LYS CYS LYS CYS HIS GLY LEU SEQRES 17 A 352 SER GLY SER CYS GLU VAL LYS THR CYS TRP TRP SER GLN SEQRES 18 A 352 PRO ASP PHE ARG ALA ILE GLY ASP PHE LEU LYS ASP LYS SEQRES 19 A 352 TYR ASP SER ALA SER GLU MET VAL VAL GLU LYS HIS ARG SEQRES 20 A 352 GLU SER ARG GLY TRP VAL GLU THR LEU ARG PRO ARG TYR SEQRES 21 A 352 THR TYR PHE LYS VAL PRO THR GLU ARG ASP LEU VAL TYR SEQRES 22 A 352 TYR GLU ALA SER PRO ASN PHE CYS GLU PRO ASN PRO GLU SEQRES 23 A 352 THR GLY SER PHE GLY THR ARG ASP ARG THR CYS ASN VAL SEQRES 24 A 352 SER SER HIS GLY ILE ASP GLY CYS ASP LEU LEU CYS CYS SEQRES 25 A 352 GLY ARG GLY HIS ASN ALA ARG ALA GLU ARG ARG ARG GLU SEQRES 26 A 352 LYS CYS ARG CYS VAL PHE HIS TRP CYS CYS TYR VAL SER SEQRES 27 A 352 CYS GLN GLU CYS THR ARG VAL TYR ASP VAL HIS THR CYS SEQRES 28 A 352 LYS SEQRES 1 B 541 MET ALA GLY ALA ILE ILE GLU ASN MET SER THR LYS LYS SEQRES 2 B 541 LEU CYS ILE VAL GLY GLY ILE LEU LEU VAL PHE GLN ILE SEQRES 3 B 541 ILE ALA PHE LEU VAL GLY GLY LEU ILE ALA PRO GLY PRO SEQRES 4 B 541 THR THR ALA VAL SER TYR MET SER VAL LYS CYS VAL ASP SEQRES 5 B 541 ALA ARG LYS ASN HIS HIS LYS THR LYS TRP PHE VAL PRO SEQRES 6 B 541 TRP GLY PRO ASN HIS CYS ASP LYS ILE ARG ASP ILE GLU SEQRES 7 B 541 GLU ALA ILE PRO ARG GLU ILE GLU ALA ASN ASP ILE VAL SEQRES 8 B 541 PHE SER VAL HIS ILE PRO LEU PRO HIS MET GLU MET SER SEQRES 9 B 541 PRO TRP PHE GLN PHE MET LEU PHE ILE LEU GLN LEU ASP SEQRES 10 B 541 ILE ALA PHE LYS LEU ASN ASN GLN ILE ARG GLU ASN ALA SEQRES 11 B 541 GLU VAL SER MET ASP VAL SER LEU ALA TYR ARG ASP ASP SEQRES 12 B 541 ALA PHE ALA GLU TRP THR GLU MET ALA HIS GLU ARG VAL SEQRES 13 B 541 PRO ARG LYS LEU LYS CYS THR PHE THR SER PRO LYS THR SEQRES 14 B 541 PRO GLU HIS GLU GLY ARG TYR TYR GLU CYS ASP VAL LEU SEQRES 15 B 541 PRO PHE MET GLU ILE GLY SER VAL ALA HIS LYS PHE TYR SEQRES 16 B 541 LEU LEU ASN ILE ARG LEU PRO VAL ASN GLU LYS LYS LYS SEQRES 17 B 541 ILE ASN VAL GLY ILE GLY GLU ILE LYS ASP ILE ARG LEU SEQRES 18 B 541 VAL GLY ILE HIS GLN ASN GLY GLY PHE THR LYS VAL TRP SEQRES 19 B 541 PHE ALA MET LYS THR PHE LEU THR PRO SER ILE PHE ILE SEQRES 20 B 541 ILE MET VAL TRP TYR TRP ARG ARG ILE THR MET MET SER SEQRES 21 B 541 ARG PRO PRO VAL LEU LEU GLU LYS VAL ILE PHE ALA LEU SEQRES 22 B 541 GLY ILE SER MET THR PHE ILE ASN ILE PRO VAL GLU TRP SEQRES 23 B 541 PHE SER ILE GLY PHE ASP TRP THR TRP MET LEU LEU PHE SEQRES 24 B 541 GLY ASP ILE ARG GLN GLY ILE PHE TYR ALA MET LEU LEU SEQRES 25 B 541 SER PHE TRP ILE ILE PHE CYS GLY GLU HIS MET MET ASP SEQRES 26 B 541 GLN HIS GLU ARG ASN HIS ILE ALA GLY TYR TRP LYS GLN SEQRES 27 B 541 VAL GLY PRO ILE ALA VAL GLY SER PHE CYS LEU PHE ILE SEQRES 28 B 541 PHE ASP MET CYS GLU ARG GLY VAL GLN LEU THR ASN PRO SEQRES 29 B 541 PHE TYR SER ILE TRP THR THR ASP ILE GLY THR GLU LEU SEQRES 30 B 541 ALA MET ALA PHE ILE ILE VAL ALA GLY ILE CYS LEU CYS SEQRES 31 B 541 LEU TYR PHE LEU PHE LEU CYS PHE MET VAL PHE GLN VAL SEQRES 32 B 541 PHE ARG ASN ILE SER GLY LYS GLN SER SER LEU PRO ALA SEQRES 33 B 541 MET SER LYS VAL ARG ARG LEU HIS TYR GLU GLY LEU ILE SEQRES 34 B 541 PHE ARG PHE LYS PHE LEU MET LEU ILE THR LEU ALA CYS SEQRES 35 B 541 ALA ALA MET THR VAL ILE PHE PHE ILE VAL SER GLN VAL SEQRES 36 B 541 THR GLU GLY HIS TRP LYS TRP GLY GLY VAL THR VAL GLN SEQRES 37 B 541 VAL ASN SER ALA PHE PHE THR GLY ILE TYR GLY MET TRP SEQRES 38 B 541 ASN LEU TYR VAL PHE ALA LEU MET PHE LEU TYR ALA PRO SEQRES 39 B 541 SER HIS LYS ASN TYR GLY GLU ASP GLN SER ASN GLY ASP SEQRES 40 B 541 LEU GLY VAL HIS SER GLY GLU GLU LEU GLN LEU THR THR SEQRES 41 B 541 THR ILE THR HIS VAL ASP GLY PRO THR GLU ILE TYR LYS SEQRES 42 B 541 LEU THR ARG LYS GLU ALA GLN GLU HET NAG H 1 14 HET NAG H 2 14 HET PAM A 501 17 HET PCW A 502 44 HET CLR B 601 28 HET LPE B 602 26 HET PCW B 603 41 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM PAM PALMITOLEIC ACID HETNAM PCW 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE HETNAM CLR CHOLESTEROL HETNAM LPE 1-O-OCTADECYL-SN-GLYCERO-3-PHOSPHOCHOLINE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN PCW (Z,Z)-4-HYDROXY-N,N,N-TRIMETHYL-10-OXO-7-[(1-OXO-9- HETSYN 2 PCW OCTADECENYL)OXY]-3,5,9-TRIOXA-4-PHOSPHAHEPTACOS-18-EN- HETSYN 3 PCW 1-AMINIUM-4-OXIDE HETSYN LPE LPC-ETHER FORMUL 3 NAG 2(C8 H15 N O6) FORMUL 4 PAM C16 H30 O2 FORMUL 5 PCW 2(C44 H85 N O8 P 1+) FORMUL 6 CLR C27 H46 O FORMUL 7 LPE C26 H57 N O6 P 1+ FORMUL 9 HOH *10(H2 O) HELIX 1 AA1 ILE A 22 TYR A 32 5 11 HELIX 2 AA2 VAL A 49 TYR A 59 1 11 HELIX 3 AA3 ILE A 62 PHE A 81 1 20 HELIX 4 AA4 GLY A 99 LYS A 104 5 6 HELIX 5 AA5 THR A 106 GLU A 130 1 25 HELIX 6 AA6 GLU A 160 ALA A 170 1 11 HELIX 7 AA7 ASP A 171 ARG A 173 5 3 HELIX 8 AA8 ASP A 178 HIS A 198 1 21 HELIX 9 AA9 ASP A 223 ALA A 238 1 16 HELIX 10 AB1 GLY A 306 CYS A 311 1 6 HELIX 11 AB2 ALA B 4 ASN B 8 5 5 HELIX 12 AB3 SER B 10 ILE B 35 1 26 HELIX 13 AB4 ASP B 76 ILE B 81 5 6 HELIX 14 AB5 ASN B 204 LYS B 208 5 5 HELIX 15 AB6 ASN B 227 MET B 258 1 32 HELIX 16 AB7 VAL B 264 ILE B 282 1 19 HELIX 17 AB8 PRO B 283 SER B 288 5 6 HELIX 18 AB9 TRP B 295 HIS B 322 1 28 HELIX 19 AC1 HIS B 331 GLY B 334 5 4 HELIX 20 AC2 TYR B 335 ASN B 363 1 29 HELIX 21 AC3 THR B 371 GLN B 411 1 41 HELIX 22 AC4 SER B 418 VAL B 455 1 38 HELIX 23 AC5 VAL B 469 TYR B 492 1 24 SHEET 1 AA1 2 HIS A 200 HIS A 206 0 SHEET 2 AA1 2 VAL A 214 SER A 220 -1 O THR A 216 N LYS A 204 SHEET 1 AA2 3 VAL A 253 PRO A 258 0 SHEET 2 AA2 3 SER A 239 HIS A 246 -1 N GLU A 244 O THR A 255 SHEET 3 AA2 3 VAL A 272 TYR A 273 1 O TYR A 273 N MET A 241 SHEET 1 AA3 2 ARG A 319 CYS A 327 0 SHEET 2 AA3 2 GLN A 340 VAL A 348 -1 O TYR A 346 N GLU A 321 SHEET 1 AA4 4 THR B 40 MET B 46 0 SHEET 2 AA4 4 GLU B 215 GLN B 226 -1 O LEU B 221 N TYR B 45 SHEET 3 AA4 4 MET B 110 ALA B 119 -1 N ALA B 119 O GLU B 215 SHEET 4 AA4 4 LEU B 182 ILE B 187 -1 O MET B 185 N PHE B 112 SHEET 1 AA5 6 LYS B 73 ILE B 74 0 SHEET 2 AA5 6 VAL B 48 VAL B 51 -1 N LYS B 49 O ILE B 74 SHEET 3 AA5 6 ILE B 90 HIS B 95 -1 O VAL B 91 N CYS B 50 SHEET 4 AA5 6 PHE B 194 ARG B 200 -1 O ILE B 199 N PHE B 92 SHEET 5 AA5 6 GLU B 131 ARG B 141 -1 N ASP B 135 O ARG B 200 SHEET 6 AA5 6 THR B 149 LYS B 159 -1 O MET B 151 N LEU B 138 SHEET 1 AA6 2 CYS B 162 THR B 163 0 SHEET 2 AA6 2 GLU B 178 CYS B 179 -1 O GLU B 178 N THR B 163 SHEET 1 AA7 2 HIS B 459 TRP B 462 0 SHEET 2 AA7 2 VAL B 465 GLN B 468 -1 O VAL B 467 N TRP B 460 SSBOND 1 CYS A 42 CYS A 56 1555 1555 2.07 SSBOND 2 CYS A 77 CYS A 88 1555 1555 2.05 SSBOND 3 CYS A 138 CYS A 155 1555 1555 2.15 SSBOND 4 CYS A 203 CYS A 217 1555 1555 2.07 SSBOND 5 CYS A 205 CYS A 212 1555 1555 2.03 SSBOND 6 CYS A 281 CYS A 312 1555 1555 2.07 SSBOND 7 CYS A 297 CYS A 307 1555 1555 2.09 SSBOND 8 CYS A 311 CYS A 351 1555 1555 2.09 SSBOND 9 CYS A 327 CYS A 342 1555 1555 2.04 SSBOND 10 CYS A 329 CYS A 339 1555 1555 2.01 SSBOND 11 CYS A 334 CYS A 335 1555 1555 2.34 SSBOND 12 CYS B 50 CYS B 71 1555 1555 2.02 SSBOND 13 CYS B 162 CYS B 179 1555 1555 2.07 LINK O4 NAG H 1 C1 NAG H 2 1555 1555 1.46 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000